These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1852156)

  • 1. Effect of dantrolene in Duchenne muscular dystrophy.
    Bertorini TE; Palmieri GM; Griffin J; Igarashi M; Hinton A; Karas JG
    Muscle Nerve; 1991 Jun; 14(6):503-7. PubMed ID: 1852156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial manual muscle testing in Duchenne muscular dystrophy.
    Kilmer DD; Abresch RT; Fowler WM
    Arch Phys Med Rehabil; 1993 Nov; 74(11):1168-71. PubMed ID: 8239956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts.
    Davis MH; Cappel R; Vester JW; Samaha FJ; Gruenstein E
    Muscle Nerve; 1982 Jan; 5(1):1-6. PubMed ID: 7057800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the creatine kinase MM isoforms of normal and Duchenne muscular dystrophic patients.
    Zhao X; Bi C; Yang Z
    Chin Med J (Engl); 1998 Jan; 111(1):75-7. PubMed ID: 10322660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical analysis of creatine kinase activity in the course of Duchenne muscular dystrophy.
    Pernice W; Guggolz MA; Guggolz M; Beckmann R; Wais U
    Muscle Nerve; 1986 May; 9(4):333-40. PubMed ID: 3713738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
    Desnuelle C; Serratrice G; N'guyen VK; Richelme C; Pinsard N
    Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper extremity functional rating for patients with Duchenne muscular dystrophy.
    Lord JP; Portwood MM; Lieberman JS; Fowler WM; Berck P
    Arch Phys Med Rehabil; 1987 Mar; 68(3):151-4. PubMed ID: 3827555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
    Vainzof M; Zatz M; Otto PA
    Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle and serum enzymes and isoenzymes in muscular dystrophies.
    Ibrahim GA; Zweber BA; Awad EA
    Arch Phys Med Rehabil; 1981 Jun; 62(6):265-9. PubMed ID: 7235920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of serum cardiac myosin light chain I in patients with muscular dystrophy].
    Saitoh M; Miyakoda H; Kitamura H; Kasagi S; Takakura H
    Rinsho Shinkeigaku; 1990 Aug; 30(8):835-9. PubMed ID: 2253417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of benefit of allopurinol in Duchenne dystrophy.
    Mendell JR; Wiechers DO
    Muscle Nerve; 1979; 2(1):53-6. PubMed ID: 397411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.
    Hauser E; Toifl K; Mad A; Bittner R
    Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing.
    Percy ME; Andrews DF; Thompson MW
    Muscle Nerve; 1982 Jan; 5(1):58-64. PubMed ID: 7057807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and identification of myoglobin in serum by immunoblotting. Effect of exercise on patients with Duchenne muscular dystrophy.
    Pöche H; Hopfenmüller W; Hoffmann M
    Clin Physiol Biochem; 1987; 5(2):103-11. PubMed ID: 3304774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.